In addition to providing excellent care, Memorial Sloan-Kettering is constantly working to improve treatments for lung cancer. Our physicians lead a large number of clinical trials that test new drugs and drug combinations, surgical and radiation therapy techniques, innovative diagnostic technologies, and strategies for preserving quality of life during and after treatment.
This means that choosing Memorial Sloan-Kettering for your care may give you access to new treatment options before they are widely available elsewhere. Our experts can help to determine which clinical trials are right for you. For more information about our clinical trials, call our physician referral service at 1-866-MSK-LUNG (1-866-675-5864), or talk with your doctor.
The following clinical trials are currently enrolling new patients. For more information about a study, choose from the list below.
| Title | Investigator |
|---|---|
|
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion [Protocol 12-169] |
Rusch, Valerie, MD |
|
A Phase I Study of LDE225 with Etoposide and Cisplatin for the Initial Treatment of Extensive Small Cell Lung Cancer [Protocol 11-206] |
Pietanza, M. Catherine, MD |
|
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment [Protocol 12-111] |
Rimner, Andreas, MD |
|
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer [Protocol 12-021] |
Pietanza, M. Catherine, MD |
|
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide [Protocol 11-003] |
Rimner, Andreas, MD |
|
A Phase III Study of Etoposide/Platinum with and without Ipilimumab in Patients with Newly Diagnosed Advanced Small Cell Lung Cancer [Protocol 12-202] |
Pietanza, M. Catherine, MD |
